Search research articles
Contact Us
Filters
Showing results (21-30 of 140) with videos related to
Page
of 14
Sort By:
Calcified Tissue International
|
April 1, 2010
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial
Ugis Gruntmanis, Steve Fordan, Hans K Ghayee, et al.
Diabetes & Metabolic Syndrome
|
December 21, 2016
The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study
Preethi Mani, Hao-Yu Ren, Ian J Neeland, et al.
Journal of the American College of Cardiology
|
October 23, 2012
The importance of the muscle and ventilatory blood pumps during exercise in patients without a subpulmonary ventricle (Fontan operation)
Keri M Shafer, Jorge A Garcia, Tony G Babb, et al.
Circulation. Cardiovascular Quality and Outcomes
|
July 3, 2014
Prediction of 30-year risk for cardiovascular mortality by fitness and risk factor levels: the Cooper Center Longitudinal Study
Chanaka D Wickramasinghe, Colby R Ayers, Sandeep Das, et al.
JAMA Cardiology
|
October 28, 2020
Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease
Ezimamaka Ajufo, Colby R Ayers, Rebecca Vigen, et al.
Journal of the American College of Cardiology
|
September 4, 2012
The relationship between C-reactive protein and atherosclerosis differs on the basis of body mass index: the Dallas Heart Study
Nitin K Gupta, James A de Lemos, Colby R Ayers, et al.
European Journal of Preventive Cardiology
|
February 19, 2015
Association between number of live births and markers of subclinical atherosclerosis: The Dallas Heart Study
Monika Sanghavi, Jacquelyn Kulinski, Colby R Ayers, et al.
Atherosclerosis
|
March 11, 2022
Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: The Dallas Heart Study
Rina Mauricio, Kavisha Singh, Monika Sanghavi, et al.
Diabetes & Vascular Disease Research
|
January 22, 2009
The effect of rosiglitazone on integrated cardiovascular performance, cardiac structure, function and myocardial triglyceride: trial design and rationale
Darren K McGuire, Raphael See, Shuaib M Abdullah, et al.
Journal of Cardiac Failure
|
September 17, 2021
Subclinical Myocardial Injury and the Phenotype of Clinical Congestion in Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction
Jennifer T Thibodeau, David D Pham, Samuel A Kelly, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 140) with videos related to
Sort By:
Page
of 14
Calcified Tissue International
|
April 1, 2010
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial
Ugis Gruntmanis, Steve Fordan, Hans K Ghayee, et al.
Diabetes & Metabolic Syndrome
|
December 21, 2016
The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study
Preethi Mani, Hao-Yu Ren, Ian J Neeland, et al.
Journal of the American College of Cardiology
|
October 23, 2012
The importance of the muscle and ventilatory blood pumps during exercise in patients without a subpulmonary ventricle (Fontan operation)
Keri M Shafer, Jorge A Garcia, Tony G Babb, et al.
Circulation. Cardiovascular Quality and Outcomes
|
July 3, 2014
Prediction of 30-year risk for cardiovascular mortality by fitness and risk factor levels: the Cooper Center Longitudinal Study
Chanaka D Wickramasinghe, Colby R Ayers, Sandeep Das, et al.
JAMA Cardiology
|
October 28, 2020
Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease
Ezimamaka Ajufo, Colby R Ayers, Rebecca Vigen, et al.
Journal of the American College of Cardiology
|
September 4, 2012
The relationship between C-reactive protein and atherosclerosis differs on the basis of body mass index: the Dallas Heart Study
Nitin K Gupta, James A de Lemos, Colby R Ayers, et al.
European Journal of Preventive Cardiology
|
February 19, 2015
Association between number of live births and markers of subclinical atherosclerosis: The Dallas Heart Study
Monika Sanghavi, Jacquelyn Kulinski, Colby R Ayers, et al.
Atherosclerosis
|
March 11, 2022
Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: The Dallas Heart Study
Rina Mauricio, Kavisha Singh, Monika Sanghavi, et al.
Diabetes & Vascular Disease Research
|
January 22, 2009
The effect of rosiglitazone on integrated cardiovascular performance, cardiac structure, function and myocardial triglyceride: trial design and rationale
Darren K McGuire, Raphael See, Shuaib M Abdullah, et al.
Journal of Cardiac Failure
|
September 17, 2021
Subclinical Myocardial Injury and the Phenotype of Clinical Congestion in Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction
Jennifer T Thibodeau, David D Pham, Samuel A Kelly, et al.
Page
of 14